Precision medicine in Type 2 diabetes: Clinical markers of insulin resistance are associated with altered short and long-term glycemic response to DPP4-inhibitor therapy

OBJECTIVE: A ‘precision’ approach to type 2 diabetes therapy would aim to target treatment according to patient characteristics. We examined if measures of insulin resistance and secretion were associated with glycemic response to DPP4-inhibitor therapy. RESEARCH DESIGN AND METHODS: We evaluated whe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Dennis, John M., Shields, Beverley M., Hill, Anita V., Knight, Bridget A., McDonald, Timothy J., Rogers, Lauren R., Weedon, Michael N., Henley, William E., Sattar, Naveed A., Holman, Rury R., Pearson, Ewan R., Hattersley, Andrew T., Jones, Angus G.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6591121/
https://ncbi.nlm.nih.gov/pubmed/29386249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc17-1827
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars